American Society of Clinical Oncology (ASCO)
JCO Precision Oncology Conversations
JCO Precision Oncology Conversations podcasts features discussions with leading authors of JCO Precision Oncology articles, hosted by Dr. Abdul Rafeh Naqash. Join our experts in engaging conversations as they examine groundbreaking research in the world of precision oncology and learn how these advancements are redefining treatment protocols. The year's fellows summarize the top JCO Precision Oncology articles in the series, JCO PO Article Insights.
Be sure to visit the podcast's website and support the creator: ascopubs.org
Author
American Society of Clinical Oncology (ASCO)
Category
Podcast website
Latest episode
Nov 3, 2026
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
Somatic Mutations of Colorectal Cancer by Birth Cohort 29.10.2025 7:33
In this episode of JCO PO Article Insights, host Dr. Jiasen He summarizes the article, " Somatic Mutation Profiles of Colorectal Cancer by Birth Cohort " by Gilad, et al published October 11, 2025. TRANSCRIPT Jiasen He: Hello, and welcome to the JCO Precision Oncology Article Insights . I am your host, Jiasen He, and today, we will be discussing the JCO Precision Oncology article, " Somatic Mutati...
Areas of Uncertainty in Pancreatic Cancer Surveillance 11.10.2025 16:57
JCO PO author Dr. Bryson Katona at the University of Pennsylvania Perelman School of Medicine shares insights into his article, " Areas of Uncertainty in Pancreatic Cancer Surveillance: A Survey Across the International Pancreatic Cancer Early Detection (PRECEDE) Consortium " Host Dr. Rafeh Naqash and Dr. Katona discuss how, given differing guidelines as well as lack of detail about how PC surveil...
Lynch Syndrome Mortality in the Immunotherapy Era 11.10.2025 26:49
JCO PO author Dr. Asaf Maoz at Dana-Farber Cancer Institute shares insights into article, " Causes of Death Among Individuals with Lynch Syndrome in the Immunotherapy Era ." Host Dr. Rafeh Naqash and Dr. Maoz discuss the causes of death in individuals with LS and the evolving role of immunotherapy. TRANSCRIPT Dr. Rafeh Naqash: Hello, and welcome to JCO Precision Oncology Conversations , where we b...
JCO PO Article Insights: A Retrospective Analysis to Identify ICI-Sensitive Populations 30.09.2025 7:47
In this JCO Precision Oncology Article Insights episode, Dr. Jiasen He summarizes JCO PO article " Synthetic Lethal Co-Mutations in DNA Damage Response Pathways Predict Response to Immunotherapy in Pan-Cancer " by Hua Zhong et al. TRANSCRIPT Jiasen He: Hello and welcome to the JCO Precision Oncology Article Insights . I am your host, Jiasen He, and today we will be discussing the JCO Precision Onc...
Genomic Profile of Small Cell Bladder, Lung and Urothelial Cancer 24.09.2025 17:03
JCO PO authors Dr. Abhishek Tripathi and Dr. Salvador Jaime-Casas at City of Hope Comprehensive Cancer Center share insights into their article, " Comparative Genomic Characterization of Small Cell Carcinoma of the Bladder Compared With Urothelial Carcinoma and Small Cell Lung Carcinoma ." Host Dr. Rafeh Naqash and Drs. Tripathi and Jaime-Casas discuss a novel understanding of the genomic alterat...
JCO PO Article Insights: MUC16 Directed BiTE Therapy in Epithelioid Sarcoma 27.08.2025 5:42
In this JCO PO Article insights episode, Dr. Jiasen He summarized the JCO PO article " Mucin 16–Directed Therapy in Pediatric Sarcomas: Case Evidence of Ubamatamab Efficacy in Epithelioid Sarcoma and Its Implications for Other Sarcoma Subtypes " by Connolly et al. TRANSCRIPT Jiasen He: Hello, and welcome to JCO Precision Oncology Article Insights . I'm your host, Jiasen He, and today we'll be disc...
BRCA-Altered Uterine Sarcoma Treated with PARP Inhibitors 20.08.2025 24:56
JCO PO author Dr. Alison M. Schram at Memorial Sloan Kettering Cancer Center shares insights into her JCO PO article, " Retrospective Analysis of BRCA-Altered Uterine Sarcoma Treated With Poly(ADP-ribose) Polymerase Inhibitors ." Host Dr. Rafeh Naqash and Dr. Schram discuss relevant genomic and clinical features of patients with BRCA-altered uterine sarcoma and the efficacy of PARPis in this popul...
JCO PO Article Insights: Prognostic Gene Expression Signature and MYC Expression in Osteosarcoma 30.07.2025 4:26
In this JCO Precision Oncology Article Insights episode, Natalie DelRocco summarizes " Prognostic Value of the G2 Expression Signature and MYC Overexpression in Childhood High-Grade Osteosarcoma " by Roelof van Ewijk et al. published on May 29, 2025. TRANSCRIPT Natalie Del Rocco: Hello, and welcome to JCO Precision Oncology Article Insights . I'm your host, Natalie DelRocco, and today we will be d...
JCO PO Article Insights: Prognostic Gene Expression Signature and MYC Expression in Osteosarcoma 30.07.2025 4:26
In this JCO Precision Oncology Article Insights episode, Natalie DelRocco summarizes " Prognostic Value of the G2 Expression Signature and MYC Overexpression in Childhood High-Grade Osteosarcoma " by Roelof van Ewijk et al. published on May 29, 2025. TRANSCRIPT Natalie Del Rocco: Hello, and welcome to JCO Precision Oncology Article Insights . I'm your host, Natalie DelRocco, and today we will be d...
JCO PO Article Insights: Real-Time Monitoring in RCC with ctDNA 25.06.2025 7:05
In this JCO Precision Oncology Article Insights episode, Natalie DelRocco summarizes " Real-Time Monitoring in Renal Cell Carcinoma With Circulating Tumor DNA: A Step Forward, but How Far? " by Zeynep B. Zengin et al. published on February 28, 2025. TRANSCRIPT The guest on this podcast episode has no disclosures to declare. Natalie DelRocco: Hello, and welcome to JCO Precision Oncology Article Ins...
A Position Paper on ctDNA Testing in Clinical Trials 18.06.2025 23:15
JCO PO author Dr. Philip Philip at Henry Ford Cancer Institute and Wayne State University shares insights into his JCO PO article, " Incorporating Circulating Tumor DNA Testing Into Clinical Trials: A Position Paper by the National Cancer Institute GI Oncology Circulating Tumor DNA Working Group ." Host Dr. Rafeh Naqash and Dr. Philip discuss how prospective trials are required to clarify the role...
JCO PO Article Insights: TMB and Real-World ICI Outcomes in Melanoma 28.05.2025 8:11
In this JCO Precision Oncology Article Insights episode, Jiasen He summarizes "Predictive Impact of Tumor Mutational Burden on Real-World Outcomes of First-Line Immune Checkpoint Inhibition in Metastatic Melanoma" by Dr. Miles C. Andrews, et al. published on June 07, 2024. Transcript The guest on this podcast episode has no disclosures to declare. Jiasen He: Hello and welcome to the JCO Precision...
Effectiveness and Cost-Effectiveness of Gene Panels in Melanoma 21.05.2025 32:53
JCO PO author Dr. Dean A. Regier at the Academy of Translational Medicine, University of British Columbia (UBC), and the School of Population and Public Health, BC Cancer Research Institute shares insights into his JCO PO article, "Clinical Effectiveness and Cost-Effectiveness of Multigene Panel Sequencing in Advanced Melanoma: A Population-Level Real-World Target Trial Emulation." Host Dr. Rafeh...
JCO PO Article Insights: Exceptional Responders with Abexinostat and Pazopanib 30.04.2025 6:44
In this JCO PO Article Insights episode, host Harold Tan summarizes Low Kynurenine Levels Among Exceptional Responders on Phase Ib Trial of the HDAC Inhibitor Abexinostat with Pazopanib by Tsang et al, published November 07, 2024. Transcript Harold Nathan Tan: Welcome to JCO Precision Oncology Article Insights , where we explore cutting-edge discoveries in the world of cancer treatment and researc...
Prognostic Artificial Intelligence Scores and Outcomes in Nonmetastatic Prostate Cancer 16.04.2025 20:49
JCO PO author Dr. Timothy Showalter at Artera and University of Virginia shares insights into his JCO PO article, " Digital Pathology–Based Multimodal Artificial Intelligence Scores and Outcomes in a Randomized Phase III Trial in Men With Nonmetastatic Castration-Resistant Prostate Cancer " . Host Dr. Rafeh Naqash and Dr. Showalter discuss how multimodal AI as a prognostic marker in nonmetastatic...
JCO PO Article Insights: Prognostic Artificial Intelligence Nonmetastatic Prostate Cancer 26.03.2025 8:36
In this JCO Precision Oncology Article Insights episode, Natalie DelRocco summarizes " Digital Pathology–Based Multimodal Artificial Intelligence Scores and Outcomes in a Randomized Phase III Trial in Men With Nonmetastatic Castration-Resistant Prostate Cancer " by Felix Y. Feng, et al published January 31, 2025. Come back for the next episode where JCO Precision Oncology Conversations host, Dr. R...
JCO PO Article Insights: Therapy of Infantile Midline Low-Grade Gliomas 20.02.2025 5:32
In this JCO Precision Oncology Article Insights episode, Jiasen He summarizes " Midline Low-Grade Gliomas of Early Childhood: Focus on Targeted Therapies. " by Dr. Ludmila Papusha et al. published on July 08, 2024. TRANSCRIPT Jiasen He: Hello and welcome to JCO Precision Oncology Article Insights . I'm your host Jiasen He, a JCO Journal' s Editorial Fellow. Today, I will provide a summary on " M...
Adagrasib Following Sotorasib-Related Hepatotoxicity 19.02.2025 22:00
JCO PO author Dr. Hatim Husain at University of California San Diego, shares insights into his JCO PO article, "A dagrasib Treatment After Sotorasib-Related Hepatotoxicity in Patients With KRASG12C-Mutated Non–Small Cell Lung Cancer: A Case Series and Literature Review ", one of the top downloaded articles of 2024. Host Dr. Rafeh Naqash and Dr. Husain discuss how to utilize real-world and clinical...
JCO PO Article Insights: ctDNA as a Prognostic Biomarker in EGC 29.01.2025 5:51
In this JCO PO Article Insights episode, Harold Nathan Tan summarizes findings from the JCO PO article, " Circulating Tumor DNA as a Prognostic Biomarker for Recurrence in Patients With Locoregional Esophagogastric Cancers With a Pathologic Complete Response ." TRANSCRIPT Harold Nathan Tan: Welcome to JCO Precision Oncology Article Insights where we explore cutting-edge discoveries in the world of...
Proteomics Predictor for Immunotherapy Benefit 15.01.2025 21:21
JCO PO author Dr. David R. Gandara at UC Davis Comprehensive Cancer Center, shares insights into his JCO PO article, " Plasma Proteome–Based Test for First-Line Treatment Selection in Metastatic Non–Small Cell Lung Cancer ," one of the Top Articles of 2024. Host Dr. Rafeh Naqash and Dr. Gandara discuss how the PROphet® blood test supports first-line immunotherapy treatment decisions for metastatic...
Transcriptome and ctDNA Associates with Pembrolizumab Benefit 18.12.2024 23:19
JCO PO authors Dr. Philippe Bedard (Staff Medical Oncologist at Princess Margaret Cancer Centre and Professor of Medicine at University of Toronto) and Dr. Alberto Hernando Calvo (Medical Oncologist at Vall d´Hebron University Hospital) share insights into their JCO PO article, " Combined Transcriptome and Circulating Tumor DNA Longitudinal Biomarker Analysis Associates With Clinical Outcomes in A...
JCO PO Article Insights: Germline Pathogenic Variants in Renal Cell Carcinoma 27.11.2024 9:34
In this JCO Precision Oncology Article Insights episode, Miki Horiguchi summarizes two articles: " Germline Susceptibility to Renal Cell Carcinoma and Implications for Genetic Screening , " by Dr. Kate I. Glennon et al. published on August 01, 2024, and " Incidental Pathogenic Variants in Renal Cell and Urothelial Carcinoma: Is It Time for Universal Screening? " by Dr. Salvador Jaime-Casas, et al....
Uptake of Aspirin Chemoprevention in Lynch Syndrome 15.11.2024 30:56
JCO PO author Dr. Michael J. Hall, Professor of Medicine, Chairman of the Department of Clinical Genetics, and Co-Leader of the Cancer Prevention and Control Program at Fox Chase Cancer Center in Philadelphia, PA, shares insights into the JCO PO article, " Uptake of Aspirin Chemoprevention in Patients with Lynch Syndrome ." Host Dr. Rafeh Naqash and Dr. Hall discuss the finding that only about 1 i...
JCO PO Article Insights: Talazoparib in Solid Tumors with BRCA1/2 Mutation 30.10.2024 6:35
In this JCO Precision Oncology Article Insights episode, Mitchell Elliot summarizes the article " Talazoparib in Patients With Solid Tumors With BRCA1/2 Mutation: Results From the Targeted Agent and Profiling Utilization Registry Study " by Dr. Jordan Srkalovic et al. published on June 12th, 2024. TRANSCRIPT Mitchell Elliott: Hello, welcome to JCO Precision Oncology Article Insights . I'm your ho...
Transcriptomic Profiling of Non-Localized Prostate Cancer 16.10.2024 27:07
JCO PO author Dr. Amar U. Kishan, Professor, Executive Vice Chair, and Chief of Genitourinary Oncology Service in the Department of Radiation Oncology at the University of California, Los Angeles, shares insights into his JCO PO article, " Transcriptomic Profiling of Primary Prostate Cancers and Nonlocalized Disease on Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomogr...
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.